NGT HealthCare II Overview
NGT HealthCare II is an impact venture capital fund investing and growing startup companies in the fields of biotechnology, pharma, bio-convergence, and medical device. The former fund, NGTVC invested in 23 medical innovative companies. The second fund, NGT Healthcare II invested already in 22 promising companies. NGT holds a franchise from the Authority for innovation to operate technological incubator in Nazareth. Among NGT HealthCare II partners are the Tehnion, Hadasit, IBI, Falcon Group Capital, Jacobs Investment Company, GIG Limited, A3 Investment Group, Arkin Holdings, OurCrowd, Salvador Pascual Sanchez Gijon, Imad and Reem Younis. NGT HealthCare II management has the experience and expertise in supporting medical startups from identifying breakthrough technologies through R&D, clinical trials, fund raising, all the way to presenting a valuable product to the market. The Fund has a 1,300 square meter facility in Nazareth including laboratories and three clean rooms. NGT HealthCare II's impact vision is to propel healthcare and life-saving technologies, encourage Arab society and contribute to a stronger economy and an inclusive and equitable Israeli society.
Latest News
growth-positive
With $92m in hand, Nazareth-based VC looks to invest in the Arab community
NGT, a venture capital firm, has launched the HealthCare II Impact Fund with a capital infusion of $92 million to support Arab-Israeli entrepreneurs in the medical industry. The fund aims to tap into the growing talent pool of Arab Israelis in the medical field and bridge the divide between Arab communities and the startup ecosystem. NGT has invested in several portfolio companies, including Plas-Free, Intragel, and Nurami Medical. The funds focus is on early-stage startups and projects in the medtech and biotech sectors. NGT has partnered with Arieli Capital, T3, and Hadasit for the fund. The article highlights the sociopolitical impact of integrating Arab communities into the medical field and the positive effects of diversity in healthcare institutions.
InvestmentPartners
growth-positive
קרן NGT גייסה 92 מיליון דולר - כדי להזניק את היזמות בחברה הערבית
NGT, a technology investment firm, has invested in biotech start-ups that focus on blood filtration. One of the start-ups, led by Prof. Abad Al Rauf Hagazi, has developed a product that can save lives by filtering blood and creating blood doses to stop life-threatening bleeding. NGT provided the start-up with an initial investment of $1 million. The start-up is currently in the final stages of development and has formed a strategic partnership with a major medical corporation in Asia.
Investment
N/A
NGT Healthcare II Fund Raised $92 Million - Israel Electronics News
The article discusses the data collection practices of Techtime, including the collection of personal data such as email addresses and names. The company collects data for business purposes such as enhancing user experience, digital marketing, and search engine optimization. The article also mentions that Techtime uses various cloud platforms and third-party providers for operating the website. The company complies with GDPR requirements and applies necessary measures to protect personal data. Users have rights over their data, including the right to request access, export, anonymization, or erasure of their personal information. The article emphasizes the companys commitment to data protection and privacy.
growth-positive
https://www.jpost.com/business-and-innovation/article-700760
The Nazareth-based NGT HealthCare II Impact Fund has announced a new fund with commitments of approximately $92 million for investments in its portfolio companies. The funds will be used to promote innovation in medical technology, with a focus on breakthrough academic and medical commercialization technologies. Special attention will be given to promoting entrepreneurship from the Arab sector. The fund plans to invest in about 25 early-stage start-up companies and 16 year zero projects in the fields of biotechnology, bio-convergence, and medical devices. NGT HealthCare II has taken on two new strategic partners: T3, the commercialization arm of the Technion, and Hadasit, the technology transfer company of Hadassah Jerusalem.
Investment
www.jpost.com/business-and-innovation/article-700760
Team Members
5
Web & Social Links
| Website | ngt-healthcare2.com/ |
Locations
Wadi el-Haj Street 13, Nazareth, Israel
Photos & Videos
1 item(s)
NGT HealthCare II Business
Business models
—
Product stage
—
Employees
—
Sector
—Target Customer
—Core Technology
—Tags (6)
medical-technologiesimpact-investingpharmaceuticalsbioconvergencemedical-devicesbiotechnologyNGT HealthCare II Financials
—
Total funding
—
Capital raised
—
Last funding
—
Funding stage
—
Total rounds
—
Investors
NGT HealthCare II Lifecycle
NGT HealthCare II News
6 articles
growth-positive
With $92m in hand, Nazareth-based VC looks to invest in the Arab community
NGT, a venture capital firm, has launched the HealthCare II Impact Fund with a capital infusion of $92 million to support Arab-Israeli entrepreneurs in the medical industry. The fund aims to tap into the growing talent pool of Arab Israelis in the medical field and bridge the divide between Arab communities and the startup ecosystem. NGT has invested in several portfolio companies, including Plas-Free, Intragel, and Nurami Medical. The funds focus is on early-stage startups and projects in the medtech and biotech sectors. NGT has partnered with Arieli Capital, T3, and Hadasit for the fund. The article highlights the sociopolitical impact of integrating Arab communities into the medical field and the positive effects of diversity in healthcare institutions.
InvestmentPartners
growth-positive
קרן NGT גייסה 92 מיליון דולר - כדי להזניק את היזמות בחברה הערבית
NGT, a technology investment firm, has invested in biotech start-ups that focus on blood filtration. One of the start-ups, led by Prof. Abad Al Rauf Hagazi, has developed a product that can save lives by filtering blood and creating blood doses to stop life-threatening bleeding. NGT provided the start-up with an initial investment of $1 million. The start-up is currently in the final stages of development and has formed a strategic partnership with a major medical corporation in Asia.
Investment
N/A
NGT Healthcare II Fund Raised $92 Million - Israel Electronics News
The article discusses the data collection practices of Techtime, including the collection of personal data such as email addresses and names. The company collects data for business purposes such as enhancing user experience, digital marketing, and search engine optimization. The article also mentions that Techtime uses various cloud platforms and third-party providers for operating the website. The company complies with GDPR requirements and applies necessary measures to protect personal data. Users have rights over their data, including the right to request access, export, anonymization, or erasure of their personal information. The article emphasizes the companys commitment to data protection and privacy.
growth-positive
https://www.jpost.com/business-and-innovation/article-700760
The Nazareth-based NGT HealthCare II Impact Fund has announced a new fund with commitments of approximately $92 million for investments in its portfolio companies. The funds will be used to promote innovation in medical technology, with a focus on breakthrough academic and medical commercialization technologies. Special attention will be given to promoting entrepreneurship from the Arab sector. The fund plans to invest in about 25 early-stage start-up companies and 16 year zero projects in the fields of biotechnology, bio-convergence, and medical devices. NGT HealthCare II has taken on two new strategic partners: T3, the commercialization arm of the Technion, and Hadasit, the technology transfer company of Hadassah Jerusalem.
Investment
www.jpost.com/business-and-innovation/article-700760
growth-positive
Nazareth is proving to be a haven for Israeli medical professionals CTech
NGT Healthcare 2, a VC firm, is benefiting from the talent in the Arab community in Nazareth, Israel. The firm focuses on early-stage companies in the life science and medical space. The Arab community in Israel comprises around 20% of the population but has approximately one-third of all doctors. Nazareth, the largest Arab city in Israel, has a pool of talented individuals ready to enter the tech space. NGT Healthcare 2 partners with the Israeli Innovation Authority (IIA) to provide public funding for medical startups. The firm believes that expanding tech ecosystems to regions like Nazareth is crucial for utilizing talent and providing opportunities for success.
InvestmentExpand
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
NGT HealthCare II Internal
Recent Updates
Tamar Harris Kedar
· tamar@ngt-healthcare2.com · Manual · 2024-12-17 10:43:40.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2025-09-17 14:20:56.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-09-10 13:06:58.000000
Tamar Harris Kedar
· tamar@ngt-healthcare2.com · Manual · 2024-06-18 11:24:14.000000
Tamar Harris Kedar
· tamar@ngt-healthcare2.com · Manual · 2023-12-06 07:33:58.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2024-06-25 15:43:02.000000
Tamar Harris Kedar
· tamar@ngt-healthcare2.com · Manual · 2023-12-06 07:16:21.000000
Tamar Harris Kedar
· tamar@ngt-healthcare2.com · Manual · 2024-12-17 10:43:42.000000
Doron Bobman
· doron.b@sncentral.org · Manual · 2025-03-30 12:34:07.000000
Tamar Harris Kedar
· tamar@ngt-healthcare2.com · Manual · 2024-12-17 10:43:42.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2025-08-11 14:12:55.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-09-10 13:06:54.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-11-29 13:41:34.000000
Tamar Harris Kedar
· tamar@ngt-healthcare2.com · Manual · 2024-06-18 10:14:32.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-09-10 13:06:54.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-09-10 13:28:42.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-09-10 13:06:54.000000
Tamar Harris Kedar
· tamar@ngt-healthcare2.com · Manual · 2023-12-06 07:44:59.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-09-10 13:11:13.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-09-10 13:07:31.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-11-29 13:10:35.000000
Tamar Harris Kedar
· tamar@ngt-healthcare2.com · Manual · 2023-12-06 07:32:04.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2024-06-25 15:24:56.000000
Tamar Harris Kedar
· tamar@ngt-healthcare2.com · Manual · 2025-09-15 07:53:10.000000
Ayelet Levi Shinebox
· ayeletlevis@sncentral.org · Manual · 2024-11-11 14:43:02.000000
Tamar Harris Kedar
· tamar@ngt-healthcare2.com · Manual · 2025-03-20 09:59:43.000000
Tamar Harris Kedar
· tamar@ngt-healthcare2.com · Manual · 2024-11-05 12:45:53.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-09-10 13:07:31.000000
Tamar Harris Kedar
· tamar@ngt-healthcare2.com · Manual · 2023-12-06 07:44:59.000000
Tamar Harris Kedar
· tamar@ngt-healthcare2.com · Manual · 2024-11-05 12:39:12.000000
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 57/100 |
| Missing | funding stage, product stage, sector, number of employees, business model, tag line, markets |
| BI Verification | Yotam Maman |
| Registrar ID | 516358744 |
| Phone | +97246098600 |
| Creator | Tamar Kedar Harris |
| Creator email | tamar.harris@gmail.com |
| Last updater | Ortal Wein |
| Updater email | ortalw@sncentral.org |
| Last update | 2023-09-10T00:00:00.000Z |
| Created | 2022-03-24T00:00:00.000Z |